Recursion Pharmaceuticals (RXRX) Tax Provisions (2023 - 2026)
Recursion Pharmaceuticals (RXRX) reported Tax Provisions of -$4.6 million for Q1 2026, down 2813.92% on a YoY basis from $169643.7 in Q1 2025, and down 23120.0% quarter-over-quarter from $20000.0 in Q4 2025.
Recursion Pharmaceuticals (RXRX) Tax Provisions (2023 - 2026) Analysis & Trends
Recursion Pharmaceuticals has reported Tax Provisions for 4 years, with the latest figure at -$4.6 million in Q1 2026.
- For the quarter ending Q1 2026, Tax Provisions fell 2813.92% year-over-year to -$4.6 million; the trailing twelve-month figure through Mar 2026 stood at -$4.6 million (down 803.55% YoY), and the FY2025 full-year result was -$136000.0, up 87.93% from the prior year.
- Tax Provisions for Q1 2026 stood at -$4.6 million, down from $20000.0 in the prior quarter.
- The five-year high for Tax Provisions was $167000.0 in Q3 2024, with the low at -$4.6 million in Q1 2026.
- Historically, Tax Provisions has averaged -$1.1 million across 4 years, with a median of -$158000.0 in 2025.
- Annual changes were most pronounced in 2025 — Tax Provisions surged 185.71% — and 2026, when it tumbled 2813.92%.
- Recursion Pharmaceuticals' Tax Provisions stood at -$4.1 million in 2023, then surged by 100.17% to $7000.0 in 2024, then surged by 185.71% to $20000.0 in 2025, then plunged by 23120.0% to -$4.6 million in 2026.
- The last three Tax Provisions figures came in at -$4.6 million (Q1 2026), $20000.0 (Q4 2025), and $3000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Recursion Pharmaceuticals | 1.71 Bn | 1.05 Bn | -6.02 Mn | -4.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.60 Mn |
| Dec 31, 2025 | 20,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Mar 31, 2025 | -158,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 167,000.00 |
| Jun 30, 2024 | -523,000.00 |
| Mar 31, 2024 | -779,000.00 |
| Dec 31, 2023 | -4.06 Mn |